Author Archives: Megan Thomas

#Biologics #Cell and gene therapy #Drug development

Yposkesi launches construction of its second commercial bioproduction site

Yposkesi, a Contract Development and Manufacturing Organisation (CDMO) specialising in cell and gene therapies, has announced the launch of project SKY, the construction of Yposkesi’s second commercial cell and gene therapy facility and new global resource for drug developers of biologics, also called ATMPs (Advanced Therapy Medicinal Products). ATMPs treat… Read More

#News

#CRO #Data #Pharma #Pharmacovigilance

Outsourcing clinical research support – time to put safety first

Increasingly, pharma companies are looking for a one-stop-shop when outsourcing clinical research support. Outsourcing without focusing on safety, however, is turning out to be a costly decision for some companies, leading to mistakes and budget overrun. Natalia Vlcek, Pharmacovigilance Manager and EU QPPV at Arriello Group, contends that it is… Read More

#Exclusive Content #News

#Drug development #Pharma #Pharmatech

Assessing IDMP maturity as the data-driven future takes form

With the latest EU IDMP guidance now published, pharma companies must now measure their readiness for the new world, in which data-based regulatory submissions run parallel with, and will ultimately replace, single-use documents. Here, Adnan Jamil, a Senior Consultant at data-driven life sciences transformation specialist, Iperion, offers step-by-step advice to… Read More

#Exclusive Content #News

#Biologics / Biotechnology #Biotherapeutics

Bio-Techne further enhances its manufacturing capabilities

Bio-Techne has partnered with Autolomous to implement an electronic batch record system, AutoloMATE, at Bio-Techne’s GMP cellular manufacturing centre. Through this partnership, Bio-Techne will be able to offer electronic records to therapeutic companies utilising its non-viral gene delivery system, TcBuster, or contract cellular manufacturing services alongside working with Autolomous to… Read More

#News

#Corning Life Sciences #Drug screening #Events #Life sciences #Tumour biology

Corning Life Sciences to host a virtual 3D Cell Culture Summit

Corning Life Sciences will be hosting a virtual 3D Cell Culture Summit, June 16-17, that will bring together industry leaders and innovators to share ideas and information, and to discuss the future of 3D applications including spheroid, organoid and tissue models 3D workflow optimisation, trends, and innovation. Some of… Read More

#News

#Antibodies #Biopharmaceutical #Collaboration #Sitting Down With

Antibody engineering: the importance of collaboration and successful partnerships

The latest DDW Sponsored Sitting Down With podcast features Melina Mathur, Product Manager for Biopharma at Twist Bioscience. Mathur talks about Twist’s antibody expertise, drawing on the company’s experience and looking at the importance of collaboration. Listen to hear Mathur discuss the company philosophy, how the pandemic has affected… Read More

#Podcasts

#Antibodies #Biopharmaceutical #Collaboration

Antibody engineering: the importance of collaboration – podcast

The latest DDW Sitting Down With podcast features Melina Mathur, Product Manager for Biopharma at Twist Bioscience. Mathur talks about Twist’s antibody expertise, drawing on the company’s experience and looking at the importance of collaboration. The company has created some successful partnerships and she explains what these look like, why… Read More

#Editor's Choice #News

#Cell painting #Drug discovery #Genetics

PerkinElmer’s support creates world’s largest public cell painting dataset

PerkinElmer is providing its PhenoVue Cell Painting Kits to the Joint Undertaking in Morphological Profiling-Cell Painting (JUMP-CP) consortium. The consortium, spearheaded by the Broad Institute of MIT and Harvard and including leading pharmaceutical companies and non-profit research organisations, is focused on creating and sharing the world’s largest, public cell imaging… Read More

#News

#Bioscience #Drug development #Drug discovery

Taconic Biosciences launches TruIMPORT importation solution

Taconic Biosciences has launched a new solution, TruIMPORT, for importing genetically engineered models from China into academia vivarium without quarantine, in collaboration with Cyagen. Researchers at non-profit institutions play a critical role in drug discovery; however, outsourcing animal model generation can be cost prohibitive or a logistical challenge. Hurdles in… Read More

#News

#Clinical trials #Covid-19 #Data #GlobalData #Immunology / Virology & Vaccines

Covid-19 vaccine and therapeutic trials show different trends

Since Covid-19 was officially declared a pandemic by the World Health Organization (WHO), the peak in total number of clinical trials for the virus was seen in the month of April 2020. There has since been a steady decrease in new clinical trial investigations, except for the months of December… Read More

#News #Trends & Analysis

#Alzheimer's #Drug development #Drug discovery #FDA #Research

Historic breakthrough in the treatment of Alzheimer’s

The US Food and Drug Administration (FDA) has approved Biogen’s regulatory application for the use of aducanumab in the treatment of Alzheimer’s disease, which removes amyloid from brains. Aducanumab is the first new Alzheimer’s drug in nearly 20 years, and there is reportedly mixed evidence over its efficacy. However, according… Read More

#News

#Covid-19 #Immunology / Virology & Vaccines #Public health #Sinovac #Vaccines

Has China approved a Covid-19 vaccine for three year olds?

The New York Times has reported that the Chairman of the Chinese drug maker Sinovac said China had approved the company’s Covid-19 vaccine for children as young as three, which the media outlet explains would make the country the first in the world to endorse a vaccine for children of… Read More

#Covid-19 #News #Trending News

#Biology #Biotechnology #Drug development #Drug discovery #Life sciences #SLAS 2021

Poster award deadlines approaching for SLAS 2021

The deadlines for the Tony B. Academic Award and the Student Poster Award for SLAS Europe 2021 is June 14, a week prior to the conference, which takes place June 23-25 digitally. SLAS’ call for poster abstracts provide opportunities to receive recognition, experience and praise for original research by a… Read More

#News

#Assay #Bioscience #Drug development #Kinetics #Video

Re-energise your kinase discovery programme

Using Promega’s NanoBRET technology, scientists at Aurelia Bioscience have implemented intracellular kinase assays designed to study the interaction of compounds on kinase targets in intact living cells. Advantages of this technique include examination of compound binding to target kinases at physiological ATP concentrations, expression of full-length kinase target… Read More

#Videos

#Data #Flow Cytometry

Bio-Rad introduces new dyes for flow cytometry

Bio-Rad has introduced three StarBright Dyes designed for flow cytometry applications. StarBright Violet 570, 670, and 710 Dyes offer improved brightness and precise excitation and emission spectra, making them suitable for use in multicolour flow cytometry panels. The line offers researchers a range of fluorescent nanoparticles conjugated to highly validated… Read More

#News

#Covid-19 #Drug discovery

Aspirin does not improve survival for Covid-19 patients

The RECOVERY trial was established as a randomised clinical trial to test a range of potential treatments for patients hospitalised with Covid-19, who are at increased risk of blood clots forming in their blood vessels, particularly in the lungs. Between November 2020 and March 2021, the RECOVERY trial included nearly… Read More

#News #Trending News